Safety of cilostazol in peripheral artery disease: a cohort from a primary healthcare electronic database

BACKGROUND: Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding. The objective of this study is to determine the relative risk of cardiovascular adverse events or haemorrhages in patients with peripheral artery disease treated with cilostazol...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:BMC Cardiovasc Disord
Prif Awduron: Real, Jordi, Serna, M Catalina, Giner-Soriano, Maria, Forés, Rosa, Pera, Guillem, Ribes, Esther, Alzamora, Maite, Marsal, Josep Ramon, Heras, Antonio, Morros, Rosa
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2018
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5941464/
https://ncbi.nlm.nih.gov/pubmed/29739318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-018-0822-4
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg